authors
- Breadner, DA
- Liu, G
- Rothenstein, J
- Verma, S
- Menjak, I
- Cheema, PK
- Juergens, Rosalyn
- Mithoowani, H
- Bains, P
- Wang, Y
- Wheatley-Price, P
- Vincent, M
1327P First-line osimertinib in patients with EGFR mutated lung cancer with uncommon mutations (OCELOT study – interim analysis)
Journal Articles
- Overview
- Research
- Identity
- Additional Document Info
- View All
Overview
status
publication date
- October 2023
has subject area
- 1112 Oncology and Carcinogenesis (FoR)
- Oncology & Carcinogenesis (Science Metrix)
published in
- Annals of Oncology Journal